newsfilter
← Latest News
PR Newswire·

New Veeva Study Builder Agent to Configure Clinical Studies in as Little as One Day

VEEV
  • Veeva Systems announced the Veeva Study Builder Agent, an AI solution that configures Veeva EDC & DQS directly from study protocols.
  • The agent utilizes existing organizational standards & the CDISC Unified Study Definitions Model (USDM) to ensure faster, more consistent, & audit-ready study builds.
  • Key capabilities include configuring EDC forms, visits, edit check rules, CQL-based listings, & automated testing with test data generation.
  • Drew Garty, Chief Technology Officer of Veeva Clinical Data, stated the tool accelerates high-quality study builds while simplifying & standardizing clinical trials.
  • The solution is part of Veeva EDC, requires no additional license, & is delivered as a Claude Cowork plugin installed via a Veeva-managed GitHub repository.
  • Early adopter availability is planned for December 2026.
  • Veeva Systems serves over 1,500 life sciences customers as a Public Benefit Corporation.
  • The company will showcase its Clinical Data solutions at the Veeva R&D & Quality Summit in Boston on October 20-21, 2026.
  • The press release includes forward-looking statements regarding product benefits, noting that actual results may differ materially from expectations.